Twelve Per Cent of 6142 Eyes Treated for Neovascular Age‐related Macular Degeneration (nAMD) Presented With Low Visual Outcome Within 2 Years. Analysis From the Swedish Macula Registry (SMR)
Acta Ophthalmologica - United States
doi 10.1111/aos.14239
Full Text
Open PDFAbstract
Available in full text
Date
September 13, 2019
Authors
Publisher
Wiley